%0 Journal Article
%T Novel immunotherapy for adult T-cell leukemia/lymphoma: Targeting aurora kinase A
%A Hiroshi Fujiwara
%A Masaki Yasukawa
%A Nicholas Paul Casey
%A Toshiki Ochi
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2016.1239006
%X Adult T-cell leukemia/lymphoma is caused by infection with HTLV-1, following a long latent period. Immunotherapy targeting Aurora kinase A, a tumor-associated antigen over-expressed in adult T-cell leukemia/lymphoma, holds great therapeutic potential. We review the evidence in favor of a therapeutic strategy combining vaccination and TCR-gene transfer against this target
%K Adult T-cell leukemia/lymphoma
%K aurora kinase A
%K engineered T cell
%K immunotherapy
%K T-cell receptor gene
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139639/